Ladrx Corporation (LADX) - News Archive

Showing 2 of 2 results.

Navigating New Horizons LadRx Corporation’s Strategic Push for Aldoxorubicin Under the FDA’s 505(b)(2) Pathway

In a notable development within the realm of biopharmaceutical innovation, LadRx Corporation (OTCQB: LADX) a company dedicated to pioneering life-saving therapeutics for cancer has announced its strategic decision to re...

Dec 12, 2024 • Biotechnology & Pharmaceuticals Industry Business Update OTCB

LadRx and ImmunityBio Conclude Strategic Termination of Aldoxorubicin Licensing Agreement

LadRx and ImmunityBio Agree to Mutual Termination of Aldoxorubicin LicenseLadRx Corporation (OTCQB: LADX), a pioneering entity in the biopharmaceutical sector, specializing in life-saving cancer therapeutics, has announ...

Jun 4, 2024 • Biotechnology & Pharmaceuticals Industry Business Update OTCB